ASX/TRI (ASX/TRI)

Australian Securities Exchange: ASX/TRI · AUD

A$0.01

+0.00 (+12.5%)· Recorded snapshot

Market cap	10.4M
Net income (ttm)	-8.8M
EPS (ttm)	-A$0.01
Shares out	1.2B
Volume	5,186,136
Beta	1.04

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -8.8M
EPS (ttm): -A$0.01
Market cap: 10.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-61.2

P25 n/aP50 n/aP75 n/a

ROIC-36.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/TRI indicators

Market & fundamental data

Available fields

168

Groups with data

Currency

AUD

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-24
Employees	6
Enterprise value	AUD 8.1M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1987
Industry	Health Information Services
Is primary listing	Yes
ISIN number	AU000000MEB8
Last earnings date	2026-02-27
Last refreshed	2026-10-30
Last stock split date	2023-10-24
Last stock split type	Reverse
Market cap	AUD 10.4M
Next earnings date	2026-11-24
Price	AUD 0.01
Price currency	AUD
Sector	Healthcare
SIC code	2870
Stock price date	2026-10-30
Symbol	asx/TRI
Website	https://trivarx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-106.66%
FCF / EV yield	-18.66%
FCF yield	-14.5%
Industry forward P/E	143.81x
Industry P/E	203.32x
P/B ratio	0.65x
Price / tangible book value	3.04x
Sector forward P/E	34.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	AUD -1.5M
ROA	-35.07%
ROA (5Y)	-15.12%
ROCE	-52.44%
ROE	-61.23%
ROE (5Y)	-48.21%
ROIC	-36.41%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	AUD 5.1M
EBIT	AUD -8.4M
EBITDA	AUD -3.3M
EPS	AUD -0.01
FCF per share	AUD -0.00
Financing cash flow	AUD 3.9M
Free cash flow	AUD -1.5M
Free cash flow minus SBC	AUD -2.2M
Investing cash flow	AUD -1.2M
Net borrowing	AUD -47,964
Net cash flow	AUD 1.2M
Net income	AUD -8.8M
Operating cash flow minus SBC	AUD -2.2M
Operating income	AUD -8.4M
Stock-based compensation	AUD 685,846

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	AUD 0.01
Debt / equity	0.01
Interest coverage	-2,440.53
Long-term assets	AUD 14M
Long-term liabilities	AUD 92,211
Net cash (debt)	AUD 2.3M
Net cash / market cap	22.3%
Net cash growth	114.81%
Net debt / equity	-0.14
Piotroski F-Score	2
Property, plant and equipment	AUD 119,777
Shareholders' equity	AUD 16M
Tangible book value	AUD 3.4M
Tangible book value per share	AUD 0.00
Total assets	AUD 16.5M
Total cash	AUD 2.4M
Total debt	AUD 128,136
Total liabilities	AUD 565,636
WACC	9.89%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	AUD 2.5M
Current liabilities	AUD 473,425
Current ratio	5.26
Net working capital	AUD -390,361
Quick ratio	5.16
Working capital	AUD 2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-85.26%
Shareholder yield	-85.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-99.9%
10Y return CAGR	-49.51%
10Y total return	-99.89%
150-day SMA	AUD 0.02
15Y price change	-99.91%
15Y return CAGR	-36.17%
15Y total return	-99.88%
1D price change	12.5%
1M price change	-18.18%
1M total return	-18.18%
1W price change	12.5%
1W total return	12.5%
1Y price change	-59.09%
1Y return CAGR	-59.12%
1Y total return	-59.09%
20-day SMA	AUD 0.01
200-day SMA	AUD 0.02
20Y price change	-99.97%
20Y return CAGR	-31.63%
20Y total return	-99.95%
3M price change	-43.75%
3M total return	-43.75%
3Y price change	-59.09%
3Y return CAGR	-25.76%
3Y total return	-59.09%
50-day SMA	AUD 0.01
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.03
52-week high date	2026-05-20
52-week low	AUD 0.01
52-week low date	2026-10-27
5Y price change	-94.38%
5Y return CAGR	-43.77%
5Y total return	-94.38%
6M price change	-50%
6M total return	-50%
All-time high	AUD 660.00
All-time high date	2001-05-22
All-time low	AUD 0.01
All-time low date	2025-07-03
Average true range (ATR)	AUD 0.00
Average volume	809.2K
Beta (1Y)	2.04
Beta (2Y)	1.91
Beta (5Y)	1.04
Change from 52-week high	-70.97%
Change from 52-week low	28.57%
Change from all-time high	-100%
Change from all-time low	28.57%
Change from open	12.5%
Day's gap	0%
Dollar volume	AUD 46,675
High price	AUD 0.01
Low price	AUD 0.01
Monthly RSI	38.17
Open price	AUD 0.01
Position in 52-week range	50%
Previous close	AUD 0.01
Price vs 150-day SMA	-49.72%
Price vs 20-day SMA	-3.23%
Price vs 200-day SMA	-52.38%
Price vs 50-day SMA	-24.37%
Relative volume	6.47
RSI	42.62
Sharpe ratio	0.55
Sharpe ratio (3Y)	0.6
Sharpe ratio (5Y)	0.76
Sortino ratio	1.4
Sortino ratio (3Y)	1.2
Sortino ratio (5Y)	1.45
Volume	5.2M
Weekly RSI	34.95
YTD price change	-52.63%
YTD total return	-52.63%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	724.8M
Shares change (QoQ)	68.22%
Shares change (YoY)	85.26%
Shares held by insiders	24.57%
Shares held by institutions	8.45%
Shares outstanding	1.2B

Deeper analysis on ASX/TRI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/TRI report

Is a complete ASX/TRI research report available?

No complete published report is available for asx/TRI (ASX/TRI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/TRI (ASX/TRI)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/TRI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/TRI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/TRI

Frequently asked questions